Financial results - ENDOCLAT MED SRL

Financial Summary - Endoclat Med Srl
Unique identification code: 22842832
Registration number: J2007001010285
Nace: 8622
Sales - Ron
26.712
Net Profit - Ron
8.827
Employees
1
Open Account
Company Endoclat Med Srl with Fiscal Code 22842832 recorded a turnover of 2024 of 26.712, with a net profit of 8.827 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Endoclat Med Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 2.601 13.525 17.896 12.278 14.862 20.392 18.057 22.156 29.162 26.712
Total Income - EUR 2.601 13.525 17.896 12.278 14.862 20.438 18.057 22.156 29.162 26.712
Total Expenses - EUR 5.685 6.133 6.384 5.504 8.589 9.341 7.436 9.291 17.845 17.204
Gross Profit/Loss - EUR -3.085 7.392 11.512 6.774 6.273 11.097 10.622 12.865 11.317 9.508
Net Profit/Loss - EUR -3.163 6.986 10.975 6.406 5.828 10.674 10.284 12.334 11.069 8.827
Employees 0 1 1 1 0 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -7.9%, from 29.162 euro in the year 2023, to 26.712 euro in 2024. The Net Profit decreased by -2.180 euro, from 11.069 euro in 2023, to 8.827 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Endoclat Med Srl

Rating financiar

Financial Rating -
ENDOCLAT MED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Endoclat Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endoclat Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Endoclat Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endoclat Med Srl - CUI 22842832

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 15.315 15.159 14.903 14.629 14.346 14.074 13.762 13.805 13.763 13.686
Current Assets 1.160 2.657 12.403 17.952 23.071 4.008 10.533 2.711 6.236 13.493
Inventories 0 0 0 43 0 662 647 649 647 643
Receivables 1.054 2.550 3.179 1.104 1.124 2.102 1.356 1.472 1.824 7.463
Cash 105 107 9.224 16.805 21.947 1.244 8.530 590 3.766 5.386
Shareholders Funds 7.302 14.214 24.948 30.896 36.125 13.036 23.032 13.132 16.074 24.811
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 9.253 3.682 2.435 1.761 1.367 5.119 1.335 3.456 3.997 2.368
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 13.493 euro in 2024 which includes Inventories of 643 euro, Receivables of 7.463 euro and cash availability of 5.386 euro.
The company's Equity was valued at 24.811 euro, while total Liabilities amounted to 2.368 euro. Equity increased by 8.827 euro, from 16.074 euro in 2023, to 24.811 in 2024.

Risk Reports Prices

Reviews - Endoclat Med Srl

Comments - Endoclat Med Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.